Clinical Trial Update: Study Evaluating Prevenar in the Prevention of Invasive Pneumococcal Disease (IPD) in the Paediatric Population in Spain.

View source ↗

Summary

Pfizer's Prevenar vaccine trial in children in Spain to prevent invasive pneumococcal disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Pneumococcal Disease

Drugs mentioned

• Prevenar (pneumococcal conjugate vaccine)

Snippet

Sponsor: Pfizer | Conditions: Invasive Pneumococcal Disease | Status: COMPLETED